Chairs: Martine Extermann (US), Barbara Van Leeuwen (NL)

11:30-11:42 – O07: An international comparison of treatment strategy and outcomes of older patients with early stage breast cancer treated in an oncogeriatric care and a standard care setting (preliminary results) – Anna de Boer (NL)
11:42-11:45 – Discussion and questions
11:45-11:57 – O08: Improved quality of life over time after colorectal cancer surgery in functionally dependent older patients – a longitudinal follow-up study – SIOG Young Investigator Award finalist Daniël Souwer (NL)
11:57-12:00Discussion and questions
12:00-12:12 – O09: Muscle density not mass predicts for survival in older adults with newly diagnosed epithelial ovarian cancer – SIOG Young Investigator Award finalistLucy Dumas (UK)
12:12-12:15 – Discussion and questions
12:15-12:27 – O10: A new treatment option for locally advanced HNSCC in elderly patients: NBTXR3 – Caroline Hoffmann (FR)
12:27-12:30 – Discussion and questions
12:30-12:42 – O11: Clinically important grade 2 and grade 3+ toxicity during treatment of metastatic castrate-resistant prostate cancer (MCRPC) in older adults – Henriette Breunis (CA)
12:42-12:45 – Discussion and questions
12:45-12:57 – O12: NORDIC 9: a randomized phase II trial evaluating optimal 1st line treatment and the predictive value of geriatric screening tools in older and frail patients with metastatic colorectal cancer – Stine Winther (DK)
12:57-13:00 – Discussion and questions